Compiled in 1996, Tatva Chintan Pharma Chem Limited is a chemical company that manufactures real estate agents (SDAs), phase transfer catalysts (PTCs), pharmaceutical and agricultural links, and other specialty chemicals. It is one of the largest SDA producers of zeolites in India.
The company works with clients in all industries namely automotive, petrol, agrochemicals, dyes and piggery, paints and clothing, medical, personal care, and others. Its products are not only sold in India but also exported to 25+ countries such as USA, Germany, South Africa, China and the UK. By FY 2020, total exports contributed 76% of total jobs.
Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and and Divi’s laboratories are a few of the company’s customers. Currently, it has two production facilities in Ankleshwar and Dahej in Gujarat.
- Leading manufacturer of structure directing agents and phase transfer catalyst.
- Diversified product portfolio.
- Global market presence with customer base across industries.
- Strategically located manufacturing facility in Gujarat with close proximity to Hazira Port.
- Experienced promoters and managers team.
- Strong financial performance track record.
Ajaykumar Mansukhlal Patel, Chintan Nitinkumar Shah, and Snehkar Rasiklal Somani are the company promoters.
|Particulars||For the year/period ended (₹ in million)|
|Profit After Tax||311.43||377.89||205.43||122.89|
Objects of the Issue
- Funding capital expenditures requirements for expansion of Dahej manufacturing facility.
- Funding capital expenditures requirements to upgrade R&D facilities in Vadodara.
- To meet general corporate purposes.
Tatva Chintan Pharma IPO – Details
|IPO Opening Date||July 16, 2021|
|IPO Closing Date||July 20, 2021|
|Issue Type||Book Built Issue IPO|
|Issue Size||500 Cr|
|Face Value||₹10 per equity share|
|IPO Price|| To  Per Equity Share|
|Market Lot||13 Shares|
|Min Order Quantity||13 Shares|
|Listing At||BSE SME|
|Total Share Issue||46,16,804 Equity Shares|
Tatva Chintan Pharma IPO – Timetable
|IPO Open Date||Jul 16, 2021|
|IPO Close Date||Jul 20, 2021|
|Basis of Allotment Date||Jul 26, 2021|
|Initiation of Refunds||Jul 27, 2021|
|Credit of Shares to Demat Account||Jul 28, 2021|
|IPO Listing Date||Jul 29, 2021|
Tatva Chintan Pharma IPO Lots Size & Price
|Application||Lots||Shares||Amount ( Cut-Off)|
Company Contact Information
|Tatva Chintan Pharma Chem Limited|
Plot No. 502 / 17, GIDC Estate, Ankleshwar,
Bharuch, Gujarat – 393002, India
Phone: +91 75730 46951
Tatva Chintan Pharma IPO FAQs
|What is Tatva Chintan Pharma IPO?|
Tatva Chintan Pharma IPO is a main-board IPO of [.] equity shares of the face value of ₹10 aggregating up to ₹500.00 Crores. The issue is priced at ₹1073 to ₹1083 per equity share. The minimum order quantity is 13 Shares.
The IPO opens on Jul 16, 2021, and closes on Jul 20, 2021.
Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
|When Tatva Chintan Pharma IPO will open?|
The Tatva Chintan Pharma IPO opens on Jul 16, 2021 and closes on Jul 20, 2021.
|What is the lot size of Tatva Chintan Pharma IPO?|
Tatva Chintan Pharma IPO lot size is 13 Shares and the minimum order quantity is 13 Shares.
|How to apply for Tatva Chintan Pharma IPO?|
You can apply in Tatva Chintan Pharma IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don’t offer banking services.
|When is Tatva Chintan Pharma IPO listing date?|
The Tatva Chintan Pharma IPO listing date is not yet announced. The tentative date of Tatva Chintan Pharma IPO listing is Jul 29, 2021.